Chris Siebel

Following academic training with a research focus on RNA biochemistry, I made the big decision to decline academic opportunities, switch fields, and begin a career in biotech. After negotiating the ups and downs at a couple of early-stage companies, I embraced the chance in 2005 to join Genentech and lead a collaborative effort to target the Notch signaling pathway. Contributing to a research community that combines the philosophy of “following the science” with a stellar track record of converting discoveries into medicines has proven extremely motivating. Genentech continues to feel like an exciting, rewarding and collaborative professional home.